ACELYRIN Revenue and Competitors
Estimated Revenue & Valuation
- ACELYRIN's estimated annual revenue is currently $18.9M per year.
- ACELYRIN's estimated revenue per employee is $155,000
- ACELYRIN's total funding is $550M.
Employee Data
- ACELYRIN has 122 Employees.
- ACELYRIN grew their employee count by -25% last year.
ACELYRIN's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief People Officer | Reveal Email/Phone |
2 | Chief Legal Officer and Head People | Reveal Email/Phone |
3 | Chief Medical Officer | Reveal Email/Phone |
4 | Chief Technical Officer | Reveal Email/Phone |
5 | Chief Commercial Officer | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | Chief Operating Officer | Reveal Email/Phone |
8 | Chief Medical Officer | Reveal Email/Phone |
9 | Head eClinical Programming & Solutions | Reveal Email/Phone |
10 | Head Global Supply Chain, External Manufacturing, and Program Management | Reveal Email/Phone |
ACELYRIN Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is ACELYRIN?
ACELYRIN, INC. is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates and leveraging its expertise to rapidly advance these medicines to patients. ACELYRIN is embedding a corporate culture of Courageous Caring™—placing patients first and embracing the concept that all of us are better than any one of us. ACELYRIN addresses the most basic human needs—to live a productive life free from diseases.
keywords:N/A
$550M
Total Funding
122
Number of Employees
$18.9M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ACELYRIN News
ACELYRIN, INC., is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and...
Affibody enters agreement with ACELYRIN for the development and commercialization of izokibep at a total deal value of USD 305 million plus royalties Tue, Nov 16, 2021 15:20 CET Solna, Sweden, November 16, 2021. Affibody AB today announced a partnership agreement with ACELYRIN, INC., (“ACELYRIN ...
LOS ANGELES, Nov. 16, 2021 /PRNewswire/ -- ACELYRIN, INC., an innovative clinical-stage biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies, today announced the completion of a $250 million Series B financing led by AyurMa ...
Affibody enters agreement with ACELYRIN for the development and commercialization of izokibep at a total deal value of USD 305 million plus royalties Tue, Nov 16, 2021 15:20 CET Solna, Sweden, November 16, 2021. Affibody AB today announced a partnership agreement with ACELYRIN, INC., (“ACELYRIN ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $30.6M | 122 | -1% | N/A |
#2 | $35M | 122 | 9% | N/A |
#3 | $18.3M | 122 | -8% | N/A |
#4 | $17.1M | 122 | 2% | N/A |
#5 | $12.2M | 122 | 9% | N/A |